A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
for
Non-muscle-invasive Bladder Cancer
Location: Dallas TX, San Antonio TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT05825950
Recruiting
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
for
Locally Advanced Bladder Urothelial Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06764095
Recruiting
Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies
for
Prostate Cancer Stage I, Kidney Cancer Stage I,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT03522155
Recruiting
Renal Retention in High Grade Upper Tract Urothelial Cancer
for
High Grade Urothelial Carcinoma, Bladder Cancer,
Location: Baltimore MD, Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT05656235
Phase2, Recruiting
Interested in new bladder cancer trials?
Get alerts for new trials in your area by subscribing now
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Halifax, Boston MA, The Bronx NY, New York NY,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
Telehealth Intervention for Ostomy Self-Management
for
Colorectal Cancer, Bladder Cancer
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06528990
Phase2, Recruiting
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
for
Metastatic Bladder Urothelial Carcinoma,
Location: Chicago IL, Orland Park IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06630416
Phase2, Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase1, Recruiting
Evaluation of the PhageTech Virus BioResistor
for
Bladder Cancer
Location: Santa Monica CA
Sponsor: PhageTech, Inc.
Sex: All
Age: 18+
Code: NCT04756284
Recruiting
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
for
Bladder Cancer
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 21+
Code: NCT02992990
Recruiting
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
for
Sarcoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06503146
Phase2, Recruiting
Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
for
Advanced Bladder Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06434350
Phase1, Phase2, Recruiting
Evaluation for NCI Surgery Branch Clinical Research Protocols